Research paperCannabis use in a Swiss male prison: Qualitative study exploring detainees’ and staffs’ perspectives
Introduction
Worldwide, cannabis is the most frequently used illegal substance: lifetime prevalence varies between less than 1–42% in adults, one-year prevalence among the adult population in Western Europe in 2009 has been estimated to be of 7.1% (Degenhardt et al., 2008, Degenhardt and Hall, 2012) and 6.9% of adults between 15 and 34 years used cannabis in the last month in Europe (EMCDDA, 2010a). Desired effects are mild euphoria, relaxation, increased sociability, sedation, analgesia, appetite and mood enhancement, anti-emetic effects, anxiolytic action and feelings of well-being (Hall and Degenhardt, 2009, Hall and Solowij, 1998). Effects of cannabis vary among subjects due to their individual differences in responding to cannabinoids, the dose, the personal experience, the mood and social setting of the use (Grotenhermen, 2007, Hall and Degenhardt, 2009).
People who use drugs are overrepresented in prison (Butler et al., 2011, Eytan et al., 2010, Fazel et al., 2006, Niveau and Ritter, 2008, WHO, 2007), with reported prevalence of drug users in prisons much higher than among the general population, and cannabis being the most frequently illegal drug used. European studies reported prevalence of cannabis use prior to imprisonment of 65% in the largest remand prison in Switzerland (Niveau & Ritter, 2008); 38% in France (Sahajian, Lamothe, & Fabry, 2006); 50–55% in the UK (Heidari et al., 2007, Stewart, 2009); 74% in Greece (Fotiadou et al., 2004) and 75% in Scotland (SPS, 2011). Data in Australia are comparable with 71% of men having a medium or high risk use (Holmwood, Marriott, & Humeniuk, 2008) and in the US, a 83% lifetime prevalence for cannabis was reported in incoming detainees (Lo & Stephens, 2000).
Although data is sparse, cannabis has also been reported to be the most frequently used illicit drug while in prison (EMCDDA, 2010b, Singleton et al., 2003). In Scotland for example, cannabis use was reported by 64% of the prisoners who reported drug use during the incarceration (one fifth) (SPS, 2011). Still, perceptions, and reasons for use during imprisonment have only rarely been explored worldwide. In previous qualitative researches, detainees have cited reasons for use such as coping with imprisonment and handling its related stress, as well as the calming and anxiolytic effects, along with improvement on sleep and psychological health (Frank and Kolind, 2008, Keene, 1997, Kolind et al., 2010). Staff has reported cannabis as harmless, and emphasised its calming, peace-keeping and happiness-inducing effect on detainees. According to their views, cannabis might also prevent the use of other drugs (Keene, 1997).
In a study using mixed methods (questionnaires, air quality measurements and interviews) to explore the attitudes of detainees and prison employees towards tobacco use in three prisons (2009–2010) in Switzerland, participants spontaneously raised the issue of cannabis in one of the settings. This matter obviously appeared to be of major concern to them. Since prison administrators were planning a change in the cannabis policy, and no study ever addressed specifically this issue in Swiss prisons, we decided to address this topic systematically in more depth during the interviews. The objective was to explore how detainees and staff perceive cannabis use in this particular setting, and to raise evidence on which prison administrators could base their new policy.
This article presents the results of this specific aspect of the study. It describes statements made about the influence of cannabis on individuals and on prison life, and it discusses the possible contribution of these statements to the design of a cannabis policy. Results of other topics of the interviews are published elsewhere (Ritter & Elger, 2013).
Section snippets
Methods
The study took place in a male post-trial detention centre with 120 detainees (main duration of stay 6 months) and 120 employees, one of the three settings of the larger study. Recruitment of participants is described elsewhere (Ritter & Elger, 2013). The cantonal research ethics committee approved the research project.
In this setting detainees work 5 days a week (agricultural production and animal care, cooking, maintenance, building, carpentry, wood working). Various sport activities are
Results
Fifty-eight participants were included: 31 male offenders (mean age 35 years) and 27 prison staff (mean age 46 years, 33% female). Their characteristics were previously described (Ritter & Elger, 2013). We present the results according to the themes of analysis. Detainees’ quotes are indicated with the code (Det), and staff with (Pers).
Discussion
This qualitative study reports attitudes on cannabis in this post trial male detention prison, considering individual and collective aspects, and comparing detainees’ and staff's perceptions. The results showed that both groups of participants estimated that cannabis use was common in that setting: detainees reported 40–80% and staff 50% prevalence. Cannabis was felt to fulfil diverse functions at the physical (analgesic) and psychological levels (help to sleep, calming, stress relieving),
Ethical approval
The cantonal (Bern, Switzerland) research ethic committee approved the research.
Funding
The Tobacco Prevention Fund at the Swiss Federal Office of Public Health (Grant Number 08.002295) provided support to do this research and submit our work for publication. The salary of one research fellow was financed through this way. One of the prerequisite was to publish research data. But the results and analysis of the study are completely independent from the funding source. Only the researchers have access to the data regarding the research (participants data, results).
Competing interests
All authors have no competing interests.
Acknowledgments
We thank the prison administrators and detainees for participating and facilitating the study.
Conflicts of interest statement
I Catherine Ritter the Corresponding Author of the submitted article disclose on the behalf of all authors any actual or potential conflict of interest, including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence the
References (51)
- et al.
The relationship among marijuana use, prior incarceration, and inmates’ self-reported HIV/AIDS risk behaviors
Addictive Behaviors
(2004) - et al.
Comparison of cannabis and tobacco withdrawal: Severity and contribution to relapse
Journal of Substance Abuse Treatment
(2008) - et al.
Extent of illicit drug use and dependence, and their contribution to the global burden of disease
Lancet
(2012) Prison life: Television, sports, work, stress and insomnia in a remand prison
International Journal of Law and Psychiatry
(2009)- et al.
Adverse health effects of non-medical cannabis use
Lancet
(2009) - et al.
Adverse effects of cannabis
Lancet
(1998) - et al.
Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb
Trends in Pharmacological Sciences
(2009) - et al.
Interventions to reduce HIV transmission related to injecting drug use in prison
The Lancet Infectious Diseases
(2009) - et al.
Drug treatment or alleviating the negative consequences of imprisonment? A critical view of prison-based drug treatment in Denmark
International Journal of Drug Policy
(2010) - et al.
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers
Drug and Alcohol Dependence
(2010)
Development of a rational scale to assess the harm of drugs of potential misuse
Lancet
Drug harms in the UK: A multicriteria decision analysis
Lancet
Second-hand tobacco smoke in prison: Tackling a public health matter through research
Public Health
Drug policy and the public good: Evidence for effective interventions
Lancet
Ranking of drugs: A more balanced risk-assessment
Lancet
Assessment of lifetime history of exposure to traumatic stressors by incarcerated adults with the Turkish version of the Traumatic Events Screening Instrument for Adults (TESI-A): A pilot study
Journal of Trauma & Dissociation
Mindfulness meditation and substance use in an incarcerated population
Psychology of Addictive Behaviors
The cannabis withdrawal syndrome
Current Opinion in Psychiatry
Co-occurring mental illness and substance use disorder among Australian prisoners
Drug and Alcohol Review
Diazepam with your dinner, Sir? The lifestyle drug-substitution strategy: A radical alcohol policy
QJM
Changes in cannabis use and its consequences over 3 years in a remote indigenous population in northern Australia
Addiction
Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys
PLoS Medicine
Endocannabinoids and exercise
British Journal of Sports Medicine
A cannabis reader: Global issues and local experiences. Monograph series 8: Vol. 1.
2010 Annual report on the state of the drugs problem in Europe
Cited by (18)
The cardiovascular health of prisoners who use cannabis: An exploratory study among hospitalised prisoners
2020, TherapiesCitation Excerpt :Cannabis, the prevalence of which remains at the highest level in the world, [3] is also of the most used psychoactive substances in prison. Cannabis use was described as part of the prisoners’ daily life, even in countries where it is illegal [4]. In France, according to the observation of illegal drugs and misuse of psychotropic medications (OPPIDUM) program, the prevalence of cannabis use in entering prisoners is 45% (versus 40% among free subjects, P < 0.001) [5].
The association between substance use and physical victimization among incarcerated men in Spanish prisons
2017, International Journal of Law and PsychiatryDrugs and discretionary power in prisons: The officer's perspective
2015, International Journal of Drug PolicyCitation Excerpt :Drugs play an increasing role in contemporary European prison life. The proportion of the prison population who use drugs is much higher than in the general population (Ritter, Broers, & Elger, 2013). In the Nordic countries,1 approximately 60% of inmates report drug use prior to imprisonment (Heltberg, 2012).
The risk matrix: Drug-related deaths in prisons in England and Wales, 2015–2020
2023, Journal of Community Psychology‘I cannot stop taking weed cos it makes me survive’: cannabis use, criminal sanctions and users’ experiences in Nigeria
2023, Drugs: Education, Prevention and PolicyEXPLORING THE MOTIVATIONS AND SOCIAL ORGANISATION OF INTOXICATION IN PRISON SETTINGS
2022, Routledge Handbook of Intoxicants and Intoxication